540686
vs
B
BSE Sensex 30
540686
Over the past 12 months, SMRUTHIORG has underperformed BSE Sensex 30, delivering a return of +3% compared to the BSE Sensex 30's +10% growth.
Stocks Performance
540686 vs BSE Sensex 30
Performance Gap
540686 vs BSE Sensex 30
Performance By Year
540686 vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Smruthi Organics Ltd
Glance View
Smruthi Organics Ltd. engages in the manufacture and sale of bulk drugs and drug intermediates. The company is headquartered in Solapur, Maharashtra. The company went IPO on 2017-08-29. The Company’s operating segments include Formulation. The firm's products include AMLODIPINE BESILATE, AMISULPRIDE, CARBIDOPA, CIPROFLOXACIN, DILOXANIDE FUROATE, FENOFIBRATE, METFORMIN HYDROCHLORIDE, NORFLOXACIN, PEFLOXACIN, TELMISARTAN, AMLODIPINE BASE and PHTHALOYL AMLODIPINE. The firm has 2 manufacturing facilities in Solapur, Maharashtra. with a combined reactor capacity of over 320 kiloliters. The firm manufactures API from kilo to metric ton scale. The firm serves pharmaceutical companies in India and across the globe. The firm caters to both domestic and international markets.
